Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2023

Transition from hormone-sensitive to castration-resistant prostate cancer

Use of PARP inhibitors in prostate cancer: Current data and future directions

Date

03 Dec 2023

Session

Transition from hormone-sensitive to castration-resistant prostate cancer

Topics

Tumour Site

Prostate Cancer

Presenters

Arun Azad

Authors

A. Azad

Author affiliations

  • Oncology Department, Peter MacCallum Cancer Centre, 3000 - Melbourne/AU

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Progression of the case

Presenter: Marniza Saad

Session: Transition from hormone-sensitive to castration-resistant prostate cancer

Resources:

Slides

Webcast

PSMA imaging and theranostics

Presenter: Sue Ping Thang

Session: Transition from hormone-sensitive to castration-resistant prostate cancer

Resources:

Slides

Webcast

Q&A and discussion

Presenter: All Speakers

Session: Transition from hormone-sensitive to castration-resistant prostate cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.